Jon Mordal

482 total citations
22 papers, 352 citations indexed

About

Jon Mordal is a scholar working on Epidemiology, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jon Mordal has authored 22 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Psychiatry and Mental health and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jon Mordal's work include Schizophrenia research and treatment (9 papers), Substance Abuse Treatment and Outcomes (8 papers) and Opioid Use Disorder Treatment (6 papers). Jon Mordal is often cited by papers focused on Schizophrenia research and treatment (9 papers), Substance Abuse Treatment and Outcomes (8 papers) and Opioid Use Disorder Treatment (6 papers). Jon Mordal collaborates with scholars based in Norway, Denmark and Sweden. Jon Mordal's co-authors include Jørgen G. Bramness, Jørg Mørland, Björn Holm, Hallvard Gjerde, Asbjørg S. Christophersen, Eivind Andersen, Jens Egeland, John Abel Engh, Gunnar Morken and Egil W. Martinsen and has published in prestigious journals such as Schizophrenia Bulletin, Psychoneuroendocrinology and Psychiatry Research.

In The Last Decade

Jon Mordal

19 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon Mordal Norway	10	140	102	72	64	51	22	352
Phunnapa Kittirattanapaiboon Thailand	10	112 0.8×	104 1.0×	24 0.3×	65 1.0×	67 1.3×	21	317
Eline Borger Rognli Norway	14	252 1.8×	151 1.5×	60 0.8×	94 1.5×	157 3.1×	32	552
Caroline Lücke Germany	12	147 1.1×	94 0.9×	28 0.4×	28 0.4×	34 0.7×	23	347
T. Acciavatti Italy	14	166 1.2×	275 2.7×	114 1.6×	96 1.5×	78 1.5×	27	572
Shao‐Chun Ree Taiwan	11	283 2.0×	112 1.1×	69 1.0×	84 1.3×	162 3.2×	15	482
Helena Vorma Finland	9	187 1.3×	69 0.7×	41 0.6×	100 1.6×	146 2.9×	24	431
Anahita Bassir Nia United States	10	59 0.4×	140 1.4×	51 0.7×	36 0.6×	60 1.2×	23	310
Nicholas W. Carrellas United States	10	156 1.1×	115 1.1×	16 0.2×	41 0.6×	27 0.5×	17	345
Mike A. McPhillips United Kingdom	9	235 1.7×	130 1.3×	26 0.4×	59 0.9×	83 1.6×	16	450
Cheng‐Cheng Hsiao Taiwan	12	162 1.2×	67 0.7×	15 0.2×	50 0.8×	49 1.0×	20	412

Countries citing papers authored by Jon Mordal

Since Specialization

Citations

This map shows the geographic impact of Jon Mordal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Mordal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Mordal more than expected).

Fields of papers citing papers by Jon Mordal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Mordal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Mordal. The network helps show where Jon Mordal may publish in the future.

Co-authorship network of co-authors of Jon Mordal

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Mordal. A scholar is included among the top collaborators of Jon Mordal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Mordal. Jon Mordal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chalabianloo, Fatemeh, Lars Thore Fadnes, Jon Mordal, et al.. (2025). Impact of dextroamphetamine substitution on the use of illicit amphetamines in adults with amphetamine dependence: a study protocol for the multicentre double blind randomised controlled trial ATLAS4Dependence. BMJ Open. 15(10). e095383–e095383.

Weimand, Bente, Jūratė Šaltytė Benth, John‐Kåre Vederhus, et al.. (2025). Changes in quality of life during 52 weeks of extended-release naltrexone treatment, subsequent by a 1-year post-treatment period. Drug and Alcohol Dependence. 276. 112917–112917.

Solli, Kristin Klemmetsby, et al.. (2025). Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study. Journal of Pain Research. Volume 18. 827–836.

Mordal, Jon, John‐Kåre Vederhus, Arild Opheim, et al.. (2025). High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study. Addiction Science & Clinical Practice. 20(1). 50–50. 1 indexed citations

Benth, Jūratė Šaltytė, Kristin Klemmetsby Solli, Jon Mordal, et al.. (2024). Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study. European Addiction Research. 31(1). 1–12. 4 indexed citations

Engh, John Abel, Eivind Andersen, Jens Egeland, et al.. (2023). Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia—a randomized controlled trial. Frontiers in Psychiatry. 14. 1175171–1175171. 3 indexed citations

Egeland, Jens, Thor Ueland, Eivind Andersen, et al.. (2023). The relationship between the brain-derived neurotrophic factor and neurocognitive response to physical exercise in individuals with schizophrenia. Psychoneuroendocrinology. 157. 106356–106356. 2 indexed citations

Engh, John Abel, et al.. (2022). High-intensity interval training may reduce depressive symptoms in individuals with schizophrenia, putatively through improved VO2max: A randomized controlled trial. Frontiers in Psychiatry. 13. 921689–921689. 13 indexed citations

Engh, John Abel, Jens Egeland, Eivind Andersen, et al.. (2021). Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms. BMC Psychiatry. 21(1). 527–527. 6 indexed citations

10.

Egeland, Jens, et al.. (2020). High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial. European Archives of Psychiatry and Clinical Neuroscience. 271(2). 339–353. 24 indexed citations

11.

Egeland, Jens, et al.. (2020). O4.3. SHARED AND DIFFERENTIAL NEUROCOGNITIVE EFFECTS COMPARING HIGH-INTENSITY INTERVAL TRAINING AND ACTIVE VIDEO-GAMING IN SCHIZOPHRENIA – RESULTS FROM AN RCT. Schizophrenia Bulletin. 46(Supplement_1). S9–S10. 2 indexed citations

12.

Egeland, Jens, Eivind Andersen, Jon Mordal, et al.. (2019). The Association Between Cardiorespiratory Fitness and Cognition Appears Neither Related to Current Physical Activity Nor Mediated by Brain-Derived Neurotrophic Factor in a Sample of Outpatients With Schizophrenia. Frontiers in Psychiatry. 10. 785–785. 5 indexed citations

13.

Engh, John Abel, Eivind Andersen, Egil W. Martinsen, et al.. (2015). Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial. Trials. 16(1). 557–557. 26 indexed citations

14.

Mordal, Jon, et al.. (2013). Evaluation of the Alcohol Use Disorders Identification Test and the Drug Use Disorders Identification Test among Patients at a Norwegian Psychiatric Emergency Ward. European Addiction Research. 19(5). 252–260. 14 indexed citations

15.

Mordal, Jon, et al.. (2013). Influence of Drugs of Abuse and Alcohol Upon Patients Admitted to Acute Psychiatric Wards. Journal of Clinical Psychopharmacology. 33(3). 415–419. 8 indexed citations

16.

Mordal, Jon, et al.. (2012). A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards. Psychiatry Research. 206(1). 17–21. 47 indexed citations

17.

Mordal, Jon, Björn Holm, Michael Gossop, et al.. (2010). Psychoactive substance use among patients admitted to an acute psychiatric ward: Laboratory findings and associations with clinical characteristics. Nordic Journal of Psychiatry. 65(3). 208–215. 11 indexed citations

18.

Mordal, Jon, Björn Holm, Jørg Mørland, & Jørgen G. Bramness. (2010). Recent Substance Intake Among Patients Admitted to Acute Psychiatric Wards. Journal of Clinical Psychopharmacology. 30(4). 455–459. 15 indexed citations

19.

Gjerde, Hallvard, Jon Mordal, Asbjørg S. Christophersen, Jørgen G. Bramness, & Jørg Mørland. (2010). Comparison of Drug Concentrations in Blood and Oral Fluid Collected with the Intercept(R) Sampling Device. Journal of Analytical Toxicology. 34(4). 204–209. 58 indexed citations

20.

Mordal, Jon, et al.. (2009). Norwegian version of the Mini-International Neuropsychiatric Interview: Feasibility, acceptability and test-retest reliability in an acute psychiatric ward. European Psychiatry. 25(3). 172–177. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact